EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer Risk in Autoimmune and Immune-Mediated Diseases: A Narrative Review for Practising Clinicians

David Bernal-Bello iD, Begoña Frutos-Pérez, Miguel Ángel Duarte-Millán iD, María Toledano-Macías, Beatriz Jaenes-Barrios, Alejandro Morales-Ortega iD

Journal of Clinical Medicine · 23.08.2025 · 14 (17) · 5954

DOI: 10.3390/jcm14175954 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.08.2025. Verfasst von David Bernal-Bello und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, 28942 Madrid, Spain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autoimmune diseases and other immune-mediated disorders are associated with an increased risk of malignancy, influenced by chronic inflammation, immune dysregulation, and treatment-related factors. Clarifying cancer risk patterns across specific conditions is essential to improve clinical vigilance and inform screening practices.

Objective

The aim of this study was to synthesise current evidence on the association between autoimmune and immune-mediated diseases and cancer, with a focus on practical implications for clinicians.

Methods

Recent cohort studies, meta-analyses, and expert consensus documents were analysed to describe cancer epidemiology, pathogenic mechanisms, high-risk phenotypes, and treatment considerations across major autoimmune diseases and other immune-mediated conditions. The review covers idiopathic inflammatory myopathies, Sjögren’s syndrome, systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis, antiphospholipid syndrome, ANCA-associated vasculitis, giant cell arteritis, polymyalgia rheumatica, sarcoidosis, mixed connective tissue disease, IgG4-related disease, VEXAS syndrome, and eosinophilic fasciitis. Special attention was given to identifying warning features for underlying malignancy and evaluating cancer screening strategies.

Results

The magnitude and distribution of cancer risk vary across diseases. In some conditions such as dermatomyositis, systemic sclerosis or Sjögren’s syndrome, increased risk is well established, particularly for haematological and certain solid tumours. However, tumour patterns may differ across populations, and findings are not always consistent. Distinct clinical and serological features help stratify individual cancer risk and may guide the intensity of screening. The first years after disease onset often represent a window of higher vulnerability, during which intensified surveillance may be warranted in selected patients.

Conclusions

Cancer risk in autoimmune diseases should be assessed on an individual basis. Awareness of disease-specific risk factors and clinical warning signs supports early recognition of malignancy and informs screening decisions in routine practice.

Schlagwörter

Stichwörter der Autor:innen

autoimmune diseasescancer riskclinical practiceimmune-mediated diseasesimmunosuppressive therapy

Autor:innen und Institutionen

  • Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, 28942 Madrid, Spain.
  • Arroyomolinos Primary Health Care Center, Arroyomolinos, 28939 Madrid, Spain.

ORCID-Profile: David Bernal-Bello, Miguel Ángel Duarte-Millán, Alejandro Morales-Ortega

Zitieren

APA

Bernal-Bello, D., Frutos-Pérez, B., Duarte-Millán, M. Á., Toledano-Macías, M., Jaenes-Barrios, B., & Morales-Ortega, A. (2025). Cancer Risk in Autoimmune and Immune-Mediated Diseases: A Narrative Review for Practising Clinicians. Journal of Clinical Medicine, 14(17), 5954. https://doi.org/10.3390/jcm14175954

Vancouver

Bernal-Bello D, Frutos-Pérez B, Duarte-Millán MÁ, Toledano-Macías M, Jaenes-Barrios B, Morales-Ortega A. Cancer Risk in Autoimmune and Immune-Mediated Diseases: A Narrative Review for Practising Clinicians. Journal of Clinical Medicine. 2025;14(17):5954. doi:10.3390/jcm14175954

BibTeX
@article{BernalBello2025,
  author = {Bernal-Bello, David and Frutos-Pérez, Begoña and Duarte-Millán, Miguel Ángel and Toledano-Macías, María and Jaenes-Barrios, Beatriz and Morales-Ortega, Alejandro},
  title = {Cancer Risk in Autoimmune and Immune-Mediated Diseases: A Narrative Review for Practising Clinicians},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {17},
  pages = {5954},
  doi = {10.3390/jcm14175954}
}
Kostenlos starten →